It has also been reported that elevated AST or ALT levels are predictive biochemical markers for the presence of NAFLD if two basic criteria are met, namely, the exclusion of alternative chronic liver diseases and the presence of features of the MS [30]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.